Experimental in vivo cross-resistance of vinca alkaloid drugs
- 1 April 1981
- journal article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 5 (3) , 197-199
- https://doi.org/10.1007/bf00258480
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparative effects of vincristine and vindesine on cell cycle kinetics in vitroCancer Treatment Reviews, 1980
- Cross resistance between actinomycin-D, adriamycin and vincristine in a murine solid tumour in vivoBiochemical Pharmacology, 1980
- A study of the cross-resistance of vincristine and vindesine in reinduction therapy for acute lymphocytic leukemia in relapse. A report for Children's Cancer Study Group.1980
- Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomasCancer Chemotherapy and Pharmacology, 1979
- A new class of antitumor compounds: 5'-nor and 5',6'-seco derivatives of vinblastine-type alkaloidsThe Journal of Organic Chemistry, 1979
- ACTIVE EFFLUX OF DAUNORUBICIN AND ADRIAMYCIN IN SENSITIVE AND RESISTANT SUBLINES OF P388-LEUKEMIA1979
- Vindesine a short review of preclinical and first clinical dataCancer Chemotherapy and Pharmacology, 1979
- 5'-Nor anhydrovinblastineTetrahedron, 1979
- Structure-activity relationships of dimeric Catharanthus alkaloids. 1. Deacetyl vinblastine amide (vindesine) sulfateJournal of Medicinal Chemistry, 1978
- Phase I anti-cancer agents Vindesine (desacetyl vinblastine amide sulfate)Cancer Treatment Reviews, 1977